Stress & Neuroimaging Lab
- Contact Us
- Our Lab
- Research Studies
- Resources
You may be eligible for one or more of the studies listed below.
To hear more about our studies or to pparticipate in research, please call:
Danielle D. (858) 552- 8585 x2509
This study partners with a double-blind, placebo-controlled trial by Dr. Sonya Norman examining Prolonged Exposure therapy and the medication topiramate for the treatment of Veterans with comorbid PTSD and AUD. Subjects will complete one of two treatment conditions: 1) Prolonged Exposure therapy with topiramate and 2) Prolonged Exposure therapy with a placebo. Subjects will undergo fMRI scans pre- and post-treatment in order to inspect the dynamic model of fear processing and alcohol cue-reactivity as well as the effects of treatment allocation on the neural networks involved.
This study aims to learn about the effects of a computer-based protocol designed to improve positive emotions, behaviors, and associated brain systems in individuals with depression and anxiety. The results of this study may help develop procedures to reduce symptoms of depression and improve positive emotions and well-being. We are seeking volunteers who experience low mood and feelings of depression or anxiety. This is a one-time visit study during which participants will complete a brain scan, questionnaires, and computer tasks.
To participate in this study please contact Danielle at the number listed above or d2dun@health.ucsd.edu
The purpose of this study is to examine the effects of placebo versus vagus nerve stimulation on brain activity and symptomology in Veterans with Posttraumatic Stress Disorder.
The aim of this study is to collect longitudinal brain imaging data on those who acquired PTSD following combat exposure and contrast it to that of subjects who did not acquire PTSD after similar combat events. Specifically, this study is focused on separating those neural substrates that are pertinent to PTSD from those better characterized by common comorbidities, such as depression and mild traumatic brain injury. In addition, we aim to understand the predictors of dynamic change in PTSD in the context of combat stress and examine the validity of cross-sectional neural biomarkers.
This study uses fMRI to measure brain response to exposure-based or skills-based therapy in veterans with combat-related PTSD and alcoholism. Participants are randomly assigned to a treatment group and will receive an fMRI scan before and after treatment.
This study is examining the efficacy of Mantram Repetition and Present-Centered Therapy in reducing PTSD symptoms among military veterans. Participants are randomly assigned to a treatment group and will receive an fMRI scan before and after treatment.
This study uses fMRI to measure brain response to cognitive rehabilitation treatment in OIF/OEF veterans with cognitive disorder. Participants will undergo treatment for cognitive disorder and receive a brain scan both before and after treatment.